Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) [Phase 3]
Phase 3 trial comparing blinatumomab to standard chemotherapy in relapsed or refractory B-precursor acute lymphoblastic leukemia; the study …
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
Phase 1/2 trial of entinostat plus imatinib mesylate in relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia; t…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) [Phase 1]
Phase 1 study evaluating a four-drug induction regimen (vincristine, dexamethasone, doxorubicin, and PEG-asparaginase) with Metformin for re…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome [Phase 4]
This Phase 4 trial compares posaconazole to micafungin for preventing invasive fungal infections during neutropenia in patients receiving ch…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
This completed clinical trial update reports cognitive and brain-function outcomes in children treated with methotrexate for acute lymphobla…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) [Phase 2]
Phase 2 trial evaluating an allogeneic stem cell transplant regimen combining clofarabine, busulfan, and antithymocyte globulin in adults wi…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation [Phase 2]
This Phase 2 clinical trial update reports results for busulfan and clofarabine conditioning followed by allogeneic stem cell transplantatio…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia [NA]
Clinical trial update reporting that metformin reduced relapse rate in patients with B-cell precursor, Ph-negative acute lymphoblastic leuke…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]
Phase 2 trial evaluating fludarabine phosphate, melphalan, and low-dose total-body irradiation followed by donor peripheral blood stem cell …
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) [Phase 1, Phase 2]
Clinical trial update reporting safety and efficacy results for 72-hour and 120-hour infusions of rigosertib in acute myeloid leukemia and a…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Modified "Providence" Pedi Cast-Sling vs.Cast and Sling [NA]
A completed clinical trial comparing the modified 'Providence' Pedi Cast-Sling with a standard Cast and Sling; study conditions include bone…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia [EARLY_Phase 1]
Early-phase trial of a vaccine therapy for acute lymphoblastic leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: 05-001: Treatment of Acute Lymphoblastic Leukemia in Children [Phase 3]
This clinical trial update reports the completion and posting of results for a Phase 3 study evaluating treatment of acute lymphoblastic leu…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study evaluating plerixafor (AMD3100) as a stem cell mobilizer for transplantation from a sibling donor in various hematologic mal…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen with alemtuzumab, fludarabine phosphate, and total-body irradiation followed by cyclosporine…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia [NA]
A completed clinical trial evaluating Healing Touch as an adjunct for patients receiving chemotherapy for acute myeloid leukemia or acute ly…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [NA]
Clinical trial update reports results of a conditioning regimen using fludarabine and total-body irradiation followed by donor stem cell tra…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating cyclophosphamide as GVHD prophylaxis after allogeneic peripheral blood stem cell transplantation in patients with h…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia
A clinical trial update reports on gene expression analysis in tissue from patients with acute lymphoblastic leukemia; the study NCT00898261…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
Phase 2 trial evaluating haploidentical donor bone marrow transplantation in patients with high-risk hematologic cancers; results completed …
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
This ClinicalTrials.gov update reports on a completed pediatric cancer trial evaluating dactinomycin and vincristine.
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Transfusional Iron Overload Among Leukemia Survivors
A completed study examining the occurrence and implications of transfusional iron overload in survivors of acute lymphoblastic leukemia and …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the use of nilotinib and imatinib after donor stem cell transplant in patients with acute ly…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluated haploidentical allogeneic transplantation with post-transplant regulatory T-cell infusion in…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating pentostatin and lymphocyte infusion to prevent graft rejection after donor stem cell transplantation—compl…